Related Experiment Video
Updated: May 8, 2026
16:26
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Treg vaccination in autoimmune type 1 diabetes
Summary
Restoring immunological self-tolerance may prevent type 1 diabetes (T1D). Inducing regulatory T (Treg) cells using specific T-cell receptor ligands offers a promising strategy to halt autoimmune destruction of pancreatic beta cells.
Area of Science:
- Immunology
- Endocrinology
- Autoimmunity
Background:
- Foxp3⁺ regulatory T (Treg) cells are crucial for maintaining immunological self-tolerance.
- Type 1 diabetes (T1D) involves the loss of self-tolerance and destruction of pancreatic beta cells, leading to hyperglycemia.
- Current strategies aim to restore self-tolerance and prevent beta cell destruction.
Purpose of the Study:
- To review the potential of Treg cell-based therapies for preventing autoimmune type 1 diabetes.
- To discuss the mechanisms for inducing Treg cells to restore self-tolerance.
- To explore opportunities for Treg-based immunotherapies in T1D.
Main Methods:
- Review of existing literature on Treg cell induction and function.
- Analysis of T-cell receptor ligand-based strategies for Treg cell conversion.
- Discussion of immunotherapeutic approaches for T1D.
Main Results:
- Strong agonistic T-cell receptor ligands under subimmunogenic conditions efficiently convert naive CD4⁺ T cells into Foxp3⁺ Treg cells.
- Specific induction of Treg cells via self-antigen variants can restore self-tolerance.
- This approach holds promise for safe and specific prevention of T1D.
Conclusions:
- Treg cell-based tolerance induction is a viable strategy for preventing autoimmune T1D.
- Developing immunotherapies that harness Treg cells can limit autoimmunity and beta cell destruction.
- Further research into Treg-based approaches is warranted for T1D intervention.
More Related Videos
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...